SISTEM PENGHANTARAN OBAT GLIMEPIRID SEBAGAI ANTIDIABETIKA ORAL DENGAN PELEPASAN DIMODIFIKASI MELALUI PEMBENTUKAN MIKROGRANUL MUKOADHESIF UNTUK PENYAKIT DIABETES MELLITUS TIPE II
Abstract
Keywords
Full Text:
PDFReferences
Ammar, H.O., H.A. Salama, M. Ghorab, A. Mahmoud, 2006, Formulation and Biological Evaluation of
Glimepiride-Cyclodextrin-Polymer Systems, Int. J. Pharm. 309, 129-138.
Frick A, et al. Biopharmaceutical characterization of oral immediate release drug products. In vitro/in
vivo comparison of phenoxymethylpenicillin potassium, glimepiride and levofloxacin, Eur. J.
Pharm.Biopharm. 46: 305-311 (1998).
Chawdhary KPR, et al. Indian Pharmacist, 2004; 2:7-10.
Chiou, W. L. and Riegelman, S. 1971. Pharmaceutical application of solidDispersion systems. J. Pharm.
Sci. 60:1281-1302.
Liu, R., 2000, Water Insoluble Drug Formulation, Taylor and Francis Group, Boca raton, London,
New York, 493-517
Rana R.M, Randa L, Ehab A.H, Omaima N., 2013, Optimization for Glimepiride Dissolution
Enhancement Utilizing Different Carriers and Techniques, Journal of Pharmaceutical
Investigation, Springer.
Darusman, Fitrianti. 2014. Peningkatan Kelarutan dan Disolusi Glimeprid dengan Metode Kokristalisasi
[thesis], Sekolah Farmasi, Institut Teknologi Bandung, Bandung.
Darusman, Fitrianti, dkk.2015. Pra-Perlakuan Bahan Baku Obat Glimepirid Dengan Teknik Dispersi
Padat, Modifikasi Polimorf Dan Kokristalisasi Untuk Peningkatan Kelarutan Dan Laju Disolusi,
LPPM-Unisba, Bandung
Sutriyo, dkk. 2008. Pengembangan Sediaan Dengan Pelepasan Dimodifikasi Mengandung Furosemid
Sebagai Model Zat Aktif Menggunakan System Mukoadhesif, Majalah Ilmu Kefarmasian, Vol.V,
No.1, UI-Depok.
United States Pharmacopoeial Convention, 2007, The United States Pharmacopoeia 30th, US
Pharmacopoeial Convention Inc., Rockville, 2226-2227
Sweetman, S. C., (Ed), 2007, Martindale, The Complete Drug Reference, 35th Ed., Pharmaceutical
Press, London, Chicago, 399-400
Massimo, M. B., 2003, Glimepiride in Type 2 Diabetes Mellitus: Review of the Worldwide Therapeutic
Experience, Clin. Ther. 25, 799-816.
Biswal S, J.Sahoo, P.N.Murthy, 2009, Phsycochemical Properties of Glimepiride in Solid Dispersions
with Polyethylene Glycol 20000, Int.J.of Pharm. Sci and Nanotechnology, Vol. 2, issue 2, 537-
Departemen Kesehatan Republik Indonesia, 1979. Farmakope Indonesia. Edisi III. Jakarta: Direktorat
Jendral Pengawasan Obat dan Makanan.
Departemen Kesehatan Republik Indonesia. 1995. Farmakope Indonesia. Edisi
IV. Jakarta : Direktorat Jendral Pengawasan Obat dan Makanan.
Wouters, et.al., 2012, Pharmaceutical Salts and Co-Crystals, RSC Publishing, Cambridge, UK.
Ansel, Howard C. 1989. Pengantar Bentuk Sediaan Farmasi, Edisi IV, Universitas Indonesia Press,
Jakarta. Hal. 59-60, 110-134, 120-121, 155-162.
Bettini, Rugerro., Laura Bonassi, Vito Castoro, Alessandra Rossi, Lucia Zema, Andrea Gazzaniga,
Ferdinando Giordano. 2001. Solubility and conversion of carbamazepine polymorphs in supercritical
carbon dioxide, European Journal of Pharmaceutical Science 13: 281-286.